RIDA qLine® Allergy quality assessment: Register now!
R-Biopharm starts RIDA qLine® Allergy External Quality Assessment. This new tool will help to ensure the quality of the testing procedures in laboratories using RIDA qLine® Allergy and the [...]
Dear customers,
we have started to provide the documents for our products in an electronic format. These are the Instructions for Use (IFU), the Safety Data Sheets (SDS) and the Certificate of Analysis (CoA). For batches placed on the market after 01 January 2023, you can find our documents on the eIFU portal https://eifu.r-biopharm.com.
Automation in diagnosis of allergies
As allergies become more widespread, their diagnosis takes on an important role. For this purpose, laboratory tests that detect allergen-specific antibodies in the blood are indispensable tools. [...]
Virology
And again: Cold – Cough – Fever
Type I allergies
RIDA qLine® Allergy: The next generation of allergy in-vitro diagnostics
R-Biopharm AG has faced the challenge to develop a sophisticated allergy in vitro test system that combines both a quantitative determination and a very economic and easy handling.
Allergology
Allergies
R-Biopharm announces quality products distribution agreement with Microbix
Mississauga, Canada and Darmstadt, Germany, 15th May 2020 – R-Biopharm AG and Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator, announces the appointment of R-Biopharm [...]